Hypoglycemia is a significant consequence of intensive antidiabetic therapy, often linked to the use of insulin, insulin secretagogues, and the overall intensity of the antidiabetic treatment.[4–6] The identification and prevention of hypoglycemia might mitigate the consequences of diabetes by avoiding complications arising from hypoglycemia. This evidence concerns the gene INS and diabetes mellitus.